|
Opportunities for improving outcomes in pancreatic cancer patients: Characterizing the unresected “resectable” population. |
| |
|
No Relationships to Disclose |
| |
|
Employment - Cardinal Health |
Leadership - Cardinal Health |
Stock and Other Ownership Interests - Cardinal Health |
| |
|
Employment - Genentech; Hoechst; Newlink Genetics |
Stock and Other Ownership Interests - Durect Corporation; Newlink Genetics |
| |
|
Employment - Genentech; NewLink Genetics |
Stock and Other Ownership Interests - NewLink Genetics |
| |
|
Employment - Cardinal Health |
Stock and Other Ownership Interests - Cardinal Health |
| |
|
Consulting or Advisory Role - Cardinal Health (Inst) |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |